Reprogramming Cancer Cells to Build Immune Hubs: A New Strategy to Strengthen Anti-Tumour Immunity
16 November 2026
A new study identifies a strategy that converts tumour cells into type 1 conventional dendritic cell-like cells (cDC1-like cells), driving the formation of immunogenic tertiary lymphoid structures (TLSs) within tumours… Read More…









